To Determine the Fasting Bioequivalence of Reformulated OXY Tablets Manufactured at Two Different Facilities

NCT01101321 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Purdue Pharma LP